Key Details
Price
$0.20Annual ROE
-12.08%Beta
0.33Events Calendar
Next earnings date:
Mar 28, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Mar 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Price
Market cap
Technical
Dividend
Profitability
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Liquidity
Leverage
Risk & Stability
Balance Sheet
Assets
Equity
Liabilities
Debt
Expenses
Cash Flow
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
NEW YORK, NY / ACCESSWIRE / October 16, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / September 19, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / September 17, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December 1, 2021. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of the company, then known as Foresight Acquisition Corp. (FORE)), and whether the Board of PII harmed stockholders, and whether all material facts had been properly disclosed to stockholders.
FAQ
- What is the ticker symbol for P3 Health Partners?
- Does P3 Health Partners pay dividends?
- What sector is P3 Health Partners in?
- What industry is P3 Health Partners in?
- What country is P3 Health Partners based in?
- When did P3 Health Partners go public?
- Is P3 Health Partners in the S&P 500?
- Is P3 Health Partners in the NASDAQ 100?
- Is P3 Health Partners in the Dow Jones?
- When was P3 Health Partners's last earnings report?
- When does P3 Health Partners report earnings?
- Should I buy P3 Health Partners stock now?